Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity (2011)
- Authors:
- USP affiliated authors: COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP ; TAKAYANAGUI, OSVALDO MASSAITI - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.1111/j.1365-2125.2010.03874.x
- Subjects: FARMACOCINÉTICA; METABOLISMO; MEDICAMENTO (INTERAÇÃO)
- Language: Inglês
- Imprenta:
- Source:
- Título: British Journal of Clinical Pharmacology
- ISSN: 0306-5251
- Volume/Número/Paginação/Ano: v. 71, n. 4, p. 528-535, 2011
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
LIMA, Renata Monteiro et al. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. British Journal of Clinical Pharmacology, v. 71, n. 4, p. 528-535, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2010.03874.x. Acesso em: 30 dez. 2025. -
APA
Lima, R. M., Ferreira, M. A. D., Carvalho, M. de J. P., Fernandes, B. J. D., Takayanagu, O. M., Garcia, H. H., et al. (2011). Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. British Journal of Clinical Pharmacology, 71( 4), 528-535. doi:10.1111/j.1365-2125.2010.03874.x -
NLM
Lima RM, Ferreira MAD, Carvalho M de JP, Fernandes BJD, Takayanagu OM, Garcia HH, Coelho EB, Lanchote VL. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity [Internet]. British Journal of Clinical Pharmacology. 2011 ; 71( 4): 528-535.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03874.x -
Vancouver
Lima RM, Ferreira MAD, Carvalho M de JP, Fernandes BJD, Takayanagu OM, Garcia HH, Coelho EB, Lanchote VL. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity [Internet]. British Journal of Clinical Pharmacology. 2011 ; 71( 4): 528-535.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03874.x - Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics
- Influence of verapamil on the pharmacokinetics of oxcarbazepine and 10-hydroxycarbazepine enantiomers in healthy volunteers
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis
- Quantificação cromatográfica da cafeína e metabólitos em urina para avaliação da atividade CYP1A2
- Stereoselective 'alfa'-hydroxylation of metoprolol in hypertensive patients with renal failure
- Stereospecific pharmacodymamics/pharmacokinetics of metoprolol in rats
- Effect of CYP inhibitors on the stereoselective kinetic disposition of metoprolol in rats
- Stereoselective determination of citalopram by liquid chromatography-tandem mass spectrometry in human plasma for pharmacokinetic
- Chiral evaluation of fluvastatin in human plasma by high-performance liquid chromatography electrospray mass spectometry
Informações sobre o DOI: 10.1111/j.1365-2125.2010.03874.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
